🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Response and Material Removal

Based on the social media company, the service has taken down violative material and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Marketplace Operations

Research also discovered communities with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at home.

Within moments of joining one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts show black plastic parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram stated it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already encountered patients injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant medical dangers”.